首页 | 本学科首页   官方微博 | 高级检索  
     


Safety and efficacy of galantamine (Reminyl) in severe Alzheimer's disease (the SERAD study): a randomised,placebo-controlled,double-blind trial
Authors:Alistair Burns  Roberto Bernabei  Roger Bullock  Alfonso J Cruz Jentoft  Lutz Frölich  Christoph Hock  Minna Raivio  Eric Triau  Maurits Vandewoude  Anders Wimo  Elizabeth Came  Bart Van Baelen  Gerry L Hammond  Joop C van Oene  Susanne Schwalen
Affiliation:1. University of Manchester, Manchester, UK;2. Università Cattolica del Sacro Cuore, Rome, Italy;3. Kingshill Research Centre, Swindon, UK;4. Hospital Universitario Ramón y Cajal, Madrid, Spain;5. Central Institute for Mental Health, Mannheim, Germany;6. University of Zürich, Zürich, Switzerland;7. Memory Research and Treatment Centers Finland-Medical Center Hemo, Lahti, Finland;8. RVT De Wingerd, Leuven, Belgium;9. University of Antwerp, Antwerp, Belgium;10. Primary Care Nordanstig and ADRC, Karolinska Institutet, Stockholm, Sweden;11. Came Clinical Research, Devizes, UK;12. SGS Life Sciences Services, Mechelen, Belgium;13. Janssen-Cilag EMEA, Beerse, Belgium;14. Janssen-Cilag EMEA, Tilburg, Netherlands;15. University Witten/Herdecke, Witten, Germany
Abstract:
Keywords:
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号